留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

宫颈癌PICC置管化疗患者自我管理能力、心理弹性及并发症的相关性分析

钟春雨,  朱晨静,  程寅

钟春雨, 朱晨静, 程寅. 宫颈癌PICC置管化疗患者自我管理能力、心理弹性及并发症的相关性分析[J]. 中华全科医学, 2026, 24(5): 869-873. doi: 10.16766/j.cnki.issn.1674-4152.004511
引用本文: 钟春雨, 朱晨静, 程寅. 宫颈癌PICC置管化疗患者自我管理能力、心理弹性及并发症的相关性分析[J]. 中华全科医学, 2026, 24(5): 869-873. doi: 10.16766/j.cnki.issn.1674-4152.004511
ZHONG Chunyu, ZHU Chenjing, CHENG Yin. Correlation between self-management ability, psychological resilience, and complications in cervical cancer patients undergoing chemotherapy via PICC[J]. Chinese Journal of General Practice, 2026, 24(5): 869-873. doi: 10.16766/j.cnki.issn.1674-4152.004511
Citation: ZHONG Chunyu, ZHU Chenjing, CHENG Yin. Correlation between self-management ability, psychological resilience, and complications in cervical cancer patients undergoing chemotherapy via PICC[J]. Chinese Journal of General Practice, 2026, 24(5): 869-873. doi: 10.16766/j.cnki.issn.1674-4152.004511

宫颈癌PICC置管化疗患者自我管理能力、心理弹性及并发症的相关性分析

doi: 10.16766/j.cnki.issn.1674-4152.004511
基金项目: 

国家自然科学基金项目 82102850

详细信息
    通讯作者:

    程寅,E-mail:1041991286@qq.com

  • 中图分类号: R737.33

Correlation between self-management ability, psychological resilience, and complications in cervical cancer patients undergoing chemotherapy via PICC

  • 摘要:   目的  分析宫颈癌经外周静脉置入中心静脉导管(PICC)化疗患者的自我管理能力、心理弹性水平与导管相关并发症发生风险之间的关联性。  方法  收集2022年1月—2025年1月江苏省肿瘤医院收治的120例宫颈癌PICC置管化疗患者的临床资料并进行回顾性分析,按PICC置管1个月后并发症发生情况将患者分为无并发症组(95例)、并发症组(25例)。采用自我管理能力量表(SUPPH)、心理弹性量表(CD-RISC)评估患者的自我管理能力、心理弹性,采用二元logistic回归模型分析宫颈癌PICC置管化疗患者发生并发症的影响因素,采用Pearson相关分析宫颈癌PICC置管化疗患者自我管理能力与心理弹性的相关性。  结果  120例宫颈癌PICC置管化疗患者发生并发症25例(20.8%),其中最主要的并发症为感染[9例(7.5%)],有3例患者发生2种及以上并发症。120例患者CD-RISC总分为33~66(48.59±7.38)分;SUPPH总分为54~111(82.86± 10.13)分。Logistic回归模型结果显示,年龄不是宫颈癌PICC置管化疗患者发生并发症的影响因素(P>0.05),化疗次数>5次、CD-RISC评分、SUPPH评分均是宫颈癌PICC置管化疗患者发生并发症的影响因素(P < 0.05)。Pearson相关分析显示,宫颈癌PICC置管化疗患者CD-RISC评分与SUPPH评分呈正相关关系(r=0.870,P < 0.001)。  结论  宫颈癌PICC置管化疗患者的并发症主要类型为感染,患者自我管理能力和心理弹性水平与并发症的发生密切相关,化疗次数>5次、较低的CD-RISC评分和SUPPH评分均是并发症发生的独立危险因素。

     

  • 表  1  宫颈癌PICC置管化疗患者并发症发生情况

    Table  1.   Complication occurrence in patients with cervical cancer undergoing chemotherapy via PICC catheter insertion

    种类 发生(例) 轻度(例) 中度(例) 占比(%)
    感染 9 7 2 7.5
    导管堵塞 5 4 1 4.2
    静脉血栓 6 5 1 5.0
    穿刺点渗液 5 3 2 4.2
    静脉炎 3 2 1 2.5
    总发生 25 18 7 20.8
    下载: 导出CSV

    表  2  宫颈癌PICC置管化疗患者自我管理能力、心理弹性得分情况

    Table  2.   The self-management ability and psychological resilience scores of patients with cervical cancer undergoing chemotherapy via PICC catheter insertion

    项目 得分(x±s,分)
    CD-RISC量表
      自强 15.23±3.30
      坚韧 22.03±3.88
      乐观 11.33±1.95
      CD-RISC总分 48.59±7.38
    SUPPH评分
      减轻压力 54.93±8.35
      积极态度 15.48±2.62
      决策 12.46±2.59
      SUPPH总分 82.86±10.13
    下载: 导出CSV

    表  3  2组宫颈癌PICC置管化疗患者临床资料比较

    Table  3.   Comparison of clinical data of 2 groups of patients with cervical cancer undergoing PICC catheterization for chemotherapy

    项目 无并发症
    (n=95)
    并发症组
    (n=25)
    统计量 P值
    年龄[例(%)] 3.336a < 0.001
       < 40岁 61(64.2) 8(32.0)
      40~60岁 19(20.0) 5(20.0)
      >60岁 15(15.8) 12(48.0)
    教育程度[例(%)] 0.757a 0.454
      初中及以下 18(18.9) 4(16.0)
      高中 34(35.8) 13(52.0)
      大专及以上 43(45.3) 8(32.0)
    婚姻状况[例(%)] 0.590b 0.442
      已婚 45(47.4) 14(56.0)
      离异或丧偶 50(52.6) 11(44.0)
    病理分期[例(%)] 2.832b 0.092
      Ⅰ~Ⅱ期 76(80.0) 16(64.0)
      Ⅲ~Ⅳ期 19(20.0) 9(36.0)
    病理类型[例(%)] 0.002b 0.968
      鳞癌 90(94.7) 23(92.0)
      腺癌 5(5.3) 2(8.0)
    化疗次数[例(%)] 2.106a 0.024
       < 3次 21(22.1) 5(20.0)
      3~5次 54(56.8) 7(28.0)
      >5次 20(21.1) 13(52.0)
    CD-RISC评分(x±s,分) 51.01±5.92 39.40±4.66 9.079c < 0.001
    SUPPH评分(x±s,分) 86.18±7.85 70.24±7.65 9.081c < 0.001
    注:a为Z值, b为χ2值,c为t值。
    下载: 导出CSV

    表  4  自变量赋值情况

    Table  4.   The assignment situation of independent variables

    变量 赋值方法
    年龄 < 40岁=1;40~60岁=2;>60岁=3
    化疗次数 < 3次=1;3~5次=2,>5次=3
    CD-RISC评分 以实际值赋值
    SUPPH评分 以实际值赋值
    下载: 导出CSV

    表  5  宫颈癌PICC置管化疗患者发生并发症的logistic回归分析

    Table  5.   Logistic regression analysis of complications in patients with cervical cancer undergoing PICC catheterization for chemotherapy

    变量 B SE Waldχ2 P值 OR值 95% CI
    年龄(参照 < 40岁) 3.636 0.162
      年龄40~60岁 -1.234 1.348 0.838 0.360 0.291 0.021~4.086
      年龄>60岁 1.695 1.186 2.043 0.153 5.448 0.533~55.687
    化疗次数(参照 < 3次) 6.921 0.031
      化疗次数3~5次 -0.749 1.451 0.266 0.606 0.473 0.027~8.131
      化疗次数>5次 3.281 1.595 4.231 0.040 26.595 1.167~606.003
    CD-RISC总分 -0.411 0.200 4.229 0.040 0.663 0.448~0.981
    SUPPH总分 -0.310 0.156 3.938 0.047 0.733 0.540~0.996
    下载: 导出CSV
  • [1] MAYADEV J S, KE G H, MAHANTSHETTY U, et al. Global challenges of radiotherapy for the treatment of locally advanced cervical cancer[J]. Int J Gynecol Cancer, 2022, 32(3): 436-445. doi: 10.1136/ijgc-2021-003001
    [2] ABU-RUSTUM N R, YASHAR C M, AREND R, et al. NCCN GuidelinesⓇ Insights: Cervical Cancer, Version 1.2024[J]. J Natl Compr Canc Netw, 2023, 21(12): 1224-1233. doi: 10.6004/jnccn.2023.0062
    [3] SAHASRABUDDHE V V. Cervical cancer: precursors and prevention[J]. Hematol Oncol Clin North Am, 2024, 38(4): 771-781. doi: 10.1016/j.hoc.2024.03.005
    [4] GIOVANNETTI O, TOMALTY D, VELIKONJA L, et al. The human cervix: comprehensive review of innervation and clinical significance[J]. Clin Anat, 2023, 36(1): 118-127. doi: 10.1002/ca.23960
    [5] 王瑾, 许凤琴, 吕娜, 等. 宫颈癌患者心理弹性及家庭关怀度在社会支持与家庭韧性间的中介作用[J]. 安徽医学, 2024, 45(3): 360-366.

    WANG J, XU F Q, LYU N, et al. The mediating role of psychological resilience and family caring in the relationship between social support and family resilience in patients with cervical cancer[J]. Anhui Medical Journal, 2024, 45(3): 360-366.
    [6] 杨蜜, 别俊, 唐组阁, 等. 重组人粒细胞巨噬细胞集落刺激因子在宫颈癌放疗致急性放射性直肠炎的临床应用[J]. 西部医学, 2024, 36(9): 1318-1322.

    YANG M, BIE J, TANG X G, et al. Clinical application of recombinant human granulocyte macrophage colony-stimulating factor in acute radiation proctitis caused by radiotherapy for cervical cancer[J]. Medical Journal of West China, 2024, 36(9): 1318-1322.
    [7] 中国抗癌协会妇科肿瘤专业委员会. 子宫颈癌诊断与治疗指南(2021年版)[J]. 中国癌症杂志, 2021, 31(6): 474-489.

    Gynecological Tumor Professional Committee of Chinese Anti-Cancer Association. Guidelines for diagnosis and treatment of cervical cancer (2021 edition)[J]. China Oncology, 2021, 31(6): 474-489.
    [8] 倪平, 陈京立, 刘娜. 护理研究中量性研究的样本量估计[J]. 中华护理杂志, 2010, 45(4): 378-380.

    NI P, CHEN J L, LIU N. The sample size estimation hi quantitative nursing research[J]. Chinese Journal of Nursing, 2010, 45(4): 378-380.
    [9] 钱会娟. 癌症患者自我管理效能感水平的横断面研究及其影响因素分析[D]. 上海: 第二军医大学, 2011.

    QIAN H J. A cross-sectional study on the level of self-management efficacy of cancer patients and the analysis of its influencing factors[D]. Shanghai: Second Military Medical University, 2011.
    [10] WU L, TAN Y, LIU Y. Factor structure and psychometric evaluation of the Connor-Davidson resilience scale in a new employee population of China[J]. BMC Psychiatry, 2017, 17(1): 49. DOI: 10.1186/s12888-017-1219-0.
    [11] 陶雍, 毛静玉, 薛嵋, 等. 肿瘤患者PICC导管相关血流感染风险预测模型的构建[J]. 中国护理管理, 2022, 22(11): 1718-1721.

    TAO Y, MAO J Y, XUE M, et al. Construction of a prediction model for Catheter-Related Bloodstream Infection during PICC retention in cancer patients[J]. Chinese Nursing Management, 2022, 22(11): 1718-1721.
    [12] 赵博, 李宝, 赵璐丹, 等. PICC导管感染, 堵塞和静脉血栓形成的因素分析[J]. 中国国境卫生检疫杂志, 2023, 46(2): 330-332.

    ZHAO B, LI B, ZHAO L D, et al. Factor analysis of PICC catheter infection, occlusion and venous thrombosis[J]. Chinese Journal of Frontier Health and Quarantine, 2023, 46(2): 330-332.
    [13] 李乾, 赵欣, 张晓维, 等. 国内成人肿瘤患者PICC相关性血栓发生率的Meta分析[J]. 中华护理杂志, 2022, 57(3): 348-355.

    LI Q, ZHAO X, ZHANG X W, et al. Incidence of peripherally inserted central catheter-related thrombosis in Chinese adult cancer patients: a meta-analysis[J]. Chinese Journal of Nursing, 2022, 57(3): 348-355.
    [14] 于倩倩, 赵素琴, 赵丽婷, 等. 两种模型在肿瘤患者PICC相关血流感染风险预测中的应用[J]. 现代临床护理, 2024, 23(9): 10-16.

    YU Q Q, ZHAO S Q, ZHAO L T, et al. Prediction of the risk to PICC associated bloodstream infection in cancer patients: a comparative study of two prediction models[J]. Modern Clinical Nursing, 2024, 23(9): 10-16.
    [15] 周燕, 李玉梅, 申萍, 等. Orem理论指导下的分级延伸护理干预对血液疾病患者PICC置管间歇期维护及自我护理能力的影响[J]. 川北医学院学报, 2023, 38(6): 854-858.

    ZHOU Y, LI Y M, SHEN P, et al. Effect of Orem theory guided hierarchical extended care intervention on intermittent PICC maintenance and self-care ability in patients with blood diseases[J]. Journal of North Sichuan Medical College, 2023, 38(6): 854-858.
    [16] 朱园园, 崔琴, 王书霞, 等. 纽曼护理模式对PICC置管肿瘤化疗患者心理弹性及自我效能的影响[J]. 基层医学论坛, 2023, 27(9): 79-82.

    ZHU Y Y, CUI Q, WANG S X, et al. The effect of Newman's nursing model on psychological resilience and self-efficacy of oncology chemotherapy patients with PICC placement[J]. The Medical Forum, 2023, 27(9): 79-82.
    [17] 程丽. 聚焦解决模式对宫颈癌患者围术期抑郁、焦虑情绪的影响[J]. 北京医学, 2019, 41(3): 242-243.

    CHENG L. The impact of the focused intervention model on the depression and anxiety symptoms of cervical cancer patients during the perioperative period[J]. Beijing Medical Journal, 2019, 41(3): 242-243.
    [18] 翟靓鑫, 谌伦华, 张娟, 等. CT与MRI判断宫颈癌淋巴结转移的临床价值比较[J]. 西部医学, 2025, 37(4): 604-607.

    ZHAI L X, CHEN L H, ZHANG J, et al. Comparison of clinical value of CT and MRI in evaluating lymph node metastasis of cervical cancer[J]. Medical Journal of West China, 2025, 37(4): 604-607.
    [19] 谭舒文, 陈燕, 邹美英, 等. 拓展型舒适干预结合认知行为疗法对宫颈癌静脉输液港化疗患者的影响[J]. 中华全科医学, 2025, 23(11): 1968-1971, 1994. doi: 10.16766/j.cnki.issn.1674-4152.004271

    TAN S W, CHEN Y, ZOU M Y, et al. The effect of extended comfort intervention combined with cognitive behavioral therapy on patients with cervical cancer undergoing intravenous infusion port chemotherapy[J]. Chinese Journal of General Practice, 2025, 23(11): 1968-1971, 1994. doi: 10.16766/j.cnki.issn.1674-4152.004271
    [20] 赵梦秋, 晋茂生, 刘红丽, 等. MRI联合术前血清学指标及病理特征对早期宫颈癌淋巴结转移的预测价值[J]. 中华全科医学, 2023, 21(2): 199-202, 303. doi: 10.16766/j.cnki.issn.1674-4152.002844

    ZHAO M Q, JIN M S, LIU H L, et al. Prediction of lymph node metastasis in early cervical cancer by MRI combined with preoperative serological indices and pathological features[J]. Chinese Journal of General Practice, 2023, 21(2): 199-202, 303. doi: 10.16766/j.cnki.issn.1674-4152.002844
表(5)
计量
  • 文章访问数:  12
  • HTML全文浏览量:  5
  • PDF下载量:  2
  • 被引次数: 0
出版历程
  • 收稿日期:  2025-07-18
  • 网络出版日期:  2026-10-23

目录

    /

    返回文章
    返回